All Articles

A new AI can detect Parkinson's progression where the current gold standard fails. In a stunning validation, the study was led by the very scientists who created the old method.

Cemvita's breakthrough 75,000-liter scale-up turns biodiesel waste into renewable oil, paving the way for a new generation of Sustainable Aviation Fuel.

Crescent's largest-ever fund close highlights booming investor appetite for private credit and promises a major capital infusion for the U.S. lower middle market.

Nirrin Technologies launches TALOS™, a system using novel laser spectroscopy to eliminate dilution and variability, promising a new standard for biomanufacturing.

A Maine edibles brand is launching nationwide, but the real story is its strategic navigation of legal gray areas and its debut at the Food & Wine Classic.

Soccer icon Dwayne De Rosario partners with tech platform LINKSPORTS, aiming to dismantle the financial barriers that sideline one in three Canadian kids.

Amid global uncertainty, Deerpath Capital's $452M CLO reset offers a masterclass in financial strategy, prioritizing stability for long-term investors.

LA's cultural phenomenon Happy Ice expands to Downtown Disney, debuting an all-natural menu and innovative desserts. Founder Lemeir Mitchell's journey comes full circle.

Vanessa Fusco’s win is more than an award. It’s a strategic play by an industry titan, revealing how social impact is becoming a currency of growth.

As its CEO takes the stage at a key defense summit, a look at how Palladyne AI's pivot from hardware to 'embodied AI' and vertical integration is creating a new model for a defense tech prime.

A new AI agent from AlphaSense promises to do more than just find data—it executes complex tasks. We look at the tech, trust, and future of work.

Vanessa Fusco's win as top female roofer isn't just a personal victory. It signals a major shift in a male-dominated industry and a new model for social impact.

PBI-Gordon's strategic hire of Kent Luther for Pegasus Labs signals a major push in animal health, blending big pharma talent with an employee-owned model.

With $50M in pre-sales and a Cabot golf course on the horizon, Revelstoke is redefining mountain living. But can it balance luxury growth with community character?

The AI boom is hitting a thermal wall. A new solution, born from electric supercar tech, promises to slash energy use and unlock unprecedented power.

The new INYY ETF promises massive income from Intel's volatility. But a look under the hood reveals NAV erosion, capped gains, and a return of your own capital.

With a potential $4 billion on the line, CytomX and Regeneron are building a new class of cancer therapies designed to act like autonomous agents in the body.

New research reveals high-net-worth investors are abandoning traditional referrals, using AI and digital due diligence to find advisors who truly get them.

Top 20 firm Cherry Bekaert partners with Fieldguide for a massive agentic AI deployment, signaling a major industry shift from point tools to AI-native platforms.

A new $515M contract for the SPY-6 radar is more than a sale; it's a strategic play cementing U.S. tech dominance and revitalizing domestic manufacturing.